NEW YORK (AP) — Diversified health care products company Johnson & Johnson said recently it will cut about 900 jobs, mainly from its Ortho-McNeil-Janssen Pharmaceuticals unit. The cuts include a mix of attrition and hiring freezes. They are part of the company's strategy to trim its U.S. sales force and refocus its approach in the market, according to Kara Russell, spokeswoman for the Ortho-McNeil-Janssen Pharmaceuticals unit. The cuts amount to about 6 percent of J&J's overall pharmaceutical sales force. In January, the maker of baby shampoo, contraceptives and other health items forecast weaker results in 2009, blaming the global recession, unfavorable currency exchange rates and intensified pressure from both generic drugs and competitors' new products.